New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
1st December 2022
US - Rhode Island: Recreational cannabis dispensaries can begin sales from today, 1st December. Rhode Island legalised recreational cannabis in May.
23rd November 2022
US - Rhode Island: Governor Dan McKee stated yesterday that recreational cannabis sales will begin next week. The Department of Business Regulation’s Office of Cannabis Regulation has approved five medical cannabis dispensaries to begin selling recreational cannabis on 1st December.
26th May 2022
US - Rhode Island: Rhode Island yesterday (25th May) became the 19th US state to legalise recreational cannabis when governor Dan McKee signed companion bills HB 7593 and SB 2430 into law, press reports. Recreational sales are set to begin on 1st December. Adults (21+) will be able to purchase and possess up to 1 oz of cannabis. They will also be allowed to grow up to six plants (three mature) for personal use. Recreational sales will be subject to the 7% state sales tax, a 10% excise tax, and a 3% local tax. To expedite the start date for sales, medical cannabis dispensaries will be able to start sales in December by applying for and receiving a hybrid retailer licence costing $125,000.
25th May 2022
US - Rhode Island: The legislature has passed companion bills – House Bill 7593 and Senate Bill 2430 – to legalise recreational cannabis, which now head to the governor, who is expected to approve. They would allow the adult (21+) purchase and possession of up to 1 oz of cannabis and allow home growing of up to six plants (three mature) for personal use. Recreational sales would be able to begin on 1st December 2022 and would be subject to the state 7% sales tax, a 10% excise tax, and a 3% local tax.
2nd March 2022
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.